1. Home
  2. AUNA vs ALLO Comparison

AUNA vs ALLO Comparison

Compare AUNA & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUNA
  • ALLO
  • Stock Information
  • Founded
  • AUNA 1989
  • ALLO 2017
  • Country
  • AUNA Luxembourg
  • ALLO United States
  • Employees
  • AUNA N/A
  • ALLO N/A
  • Industry
  • AUNA
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AUNA
  • ALLO Health Care
  • Exchange
  • AUNA NYSE
  • ALLO Nasdaq
  • Market Cap
  • AUNA 521.9M
  • ALLO 431.9M
  • IPO Year
  • AUNA 2024
  • ALLO 2018
  • Fundamental
  • Price
  • AUNA $6.61
  • ALLO $2.07
  • Analyst Decision
  • AUNA Strong Buy
  • ALLO Buy
  • Analyst Count
  • AUNA 4
  • ALLO 12
  • Target Price
  • AUNA $13.40
  • ALLO $10.06
  • AVG Volume (30 Days)
  • AUNA 38.5K
  • ALLO 2.5M
  • Earning Date
  • AUNA 11-19-2024
  • ALLO 11-07-2024
  • Dividend Yield
  • AUNA N/A
  • ALLO N/A
  • EPS Growth
  • AUNA N/A
  • ALLO N/A
  • EPS
  • AUNA N/A
  • ALLO N/A
  • Revenue
  • AUNA $1,168,151,825.00
  • ALLO $43,000.00
  • Revenue This Year
  • AUNA $17.06
  • ALLO N/A
  • Revenue Next Year
  • AUNA $9.63
  • ALLO N/A
  • P/E Ratio
  • AUNA N/A
  • ALLO N/A
  • Revenue Growth
  • AUNA 18.72
  • ALLO 26.47
  • 52 Week Low
  • AUNA $6.17
  • ALLO $1.83
  • 52 Week High
  • AUNA $10.85
  • ALLO $5.78
  • Technical
  • Relative Strength Index (RSI)
  • AUNA N/A
  • ALLO 41.06
  • Support Level
  • AUNA N/A
  • ALLO $1.83
  • Resistance Level
  • AUNA N/A
  • ALLO $2.09
  • Average True Range (ATR)
  • AUNA 0.00
  • ALLO 0.14
  • MACD
  • AUNA 0.00
  • ALLO -0.01
  • Stochastic Oscillator
  • AUNA 0.00
  • ALLO 30.38

About AUNA AUNA S A

Auna SA is a healthcare provider. It operates hospitals and clinics in Mexico, Peru, and Colombia, and provides prepaid healthcare plans in Peru, and dental and vision plans in Mexico. Its network includes several healthcare network facilities, consisting of hospitals, outpatient, prevention, and wellness facilities. The company operates in the following segments; Oncosalud Peru, Healthcare services in Peru, Healthcare services in Colombia, and Healthcare services in Mexico. Key revenue is generated from Peru.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: